First Hawaiian Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,000
| Closed | -$941K | – | 120 |
|
|
2024
Q4 | $941K | Hold |
4,000
| – | – | 0.03% | 429 |
|
|
2024
Q3 | $1.1M | Hold |
4,000
| – | – | 0.04% | 397 |
|
|
2024
Q2 | $972K | Hold |
4,000
| – | – | 0.03% | 381 |
|
|
2024
Q1 | $598K | Hold |
4,000
| – | – | 0.02% | 537 |
|
|
2023
Q4 | $766K | Sell |
4,000
-250
| -6% | -$47.9K | 0.02% | 467 |
|
|
2023
Q3 | $753K | Hold |
4,250
| – | – | 0.03% | 451 |
|
|
2023
Q2 | $807K | Buy |
4,250
+227
| +6% | +$43.1K | 0.03% | 448 |
|
|
2023
Q1 | $806K | Sell |
4,023
-1,100
| -21% | -$220K | 0.03% | 440 |
|
|
2022
Q4 | $1.22M | Sell |
5,123
-600
| -10% | -$143K | 0.04% | 310 |
|
|
2022
Q3 | $1.15M | Hold |
5,723
| – | – | 0.04% | 298 |
|
|
2022
Q2 | $834K | Buy |
5,723
+23
| +0.4% | +$3.35K | 0.03% | 404 |
|
|
2022
Q1 | $931K | Hold |
5,700
| – | – | 0.03% | 401 |
|
|
2021
Q4 | $967K | Buy |
+5,700
| New | +$967K | 0.03% | 407 |
|
|
2019
Q1 | – | Sell |
-238
| Closed | -$17K | – | 1707 |
|
|
2018
Q4 | $17K | Sell |
238
-150
| -39% | -$10.7K | ﹤0.01% | 1319 |
|
|
2018
Q3 | $34K | Buy |
+388
| New | +$34K | ﹤0.01% | 1249 |
|